PCCA Limited is recalling six batches of Ketamine 50mg in 5ml oral solution (unlicensed medicine) and three batches of Ketamine 100mg in 5ml oral solution (unlicensed medicine).
The affected batches are as follows:
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 15806-75 | 07-July-2022 | 300ml | 08-April-2022 |
| 15806-76 | 18-July-2022 | 200ml | 19-April-2022 |
| 15806-77 | 07-August-2022 | 100ml | 09-May-2022 |
| 15806-78 | 14-August-2022 | 200ml | 16-May-2022 |
| 15806-79 | 14-August-2022 | 200ml | 16-May-2022 |
| 15806-80 | 17-August-2022 | 100ml | 19-May-2022 |
Ketamine 100mg in 5ml Oral Solution (unlicensed medicine)
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 18640-20 | 26-June-2022 | 100ml | 28-Mar-2022 |
| 18640-21 | 24-July-2022 | 100ml | 25-Apr-2022 |
| 18640-22 | 17-August-2022 | 100ml | 19-May-2022 |
The recall is precautionary due to the appearance of crystalline material and healthcare teams should quarantine affected stock and return to the company. Patients should be contacted to return affected product to their GP.
For medical information enquiries, please email: [email protected]
For stock information enquiries, please email: [email protected]